Protective Effects of Edaravone Dexborneol

Clinical trial NCT05024526 · UNKNOWN

Trial details

NCT number: NCT05024526
Sponsor: Lili Cao
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Acute Ischemic Stroke

Start date: 2021-04-01
Primary completion: 2022-12-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.